Uzedy: Uses and Side Effects
I cannot provide information about Uzedy based on the evidence provided, as none of the studies or guidelines reference this medication. The evidence supplied exclusively discusses tuberculosis medications (cycloserine, ethionamide, streptomycin), combination TB drugs (Akurit-4), and other unrelated medications (mebeverine, methimazole, abelacimab, tirzepatide, upadacitinib, and Withania somnifera).
What is Uzedy?
Based on general medical knowledge, Uzedy (risperidone extended-release injectable suspension) is a long-acting antipsychotic medication approved for the treatment of schizophrenia in adults. It is administered as a subcutaneous injection once monthly or once every two months.
Primary Uses
- Treatment of schizophrenia in adults - administered as a monthly or bimonthly subcutaneous injection for maintenance therapy
Common Side Effects
Without access to the FDA drug label or clinical guidelines for Uzedy in the provided evidence, I cannot provide specific, evidence-based side effect information with proper citations.
To obtain accurate, evidence-based information about Uzedy's side effects, you should:
- Consult the FDA-approved prescribing information (drug label)
- Review current American Psychiatric Association guidelines on antipsychotic medications
- Examine recent clinical trials specifically evaluating Uzedy's safety profile
The evidence provided does not contain relevant information to answer this question about Uzedy with appropriate medical citations.